These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10378670)

  • 21. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA; Kelly K
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
    Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
    Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.
    Chatelut E; Chevreau C; Blancy E; Lequellec A; Canal P; Roche H; Houin G; Bugat R
    Cancer Chemother Pharmacol; 1990; 26(5):365-8. PubMed ID: 2170043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
    Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of an etoposide infused over three days: concomitant infusion with cisplatin.
    Minami H; Horio Y; Sakai S; Saka H; Shimokata K
    Jpn J Clin Oncol; 1991 Dec; 21(6):400-5. PubMed ID: 1666659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of high-dose etoposide, high-dose cisplatin, and reinfusion of autologous bone marrow for lung cancer.
    Lazarus HM; Spitzer TR; Creger RJ
    Am J Clin Oncol; 1990 Apr; 13(2):107-12. PubMed ID: 2156415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
    J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of high-dose cisplatin, ifosfamide, and etoposide.
    Perez EA; Sowray PC; Gardner SL; Gandara DR
    Cancer Chemother Pharmacol; 1994; 34(4):331-4. PubMed ID: 8033300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of a carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer.
    Nakano H; Tsuchiya S; Takei Y; Minato K; Watanabe S; Makimoto T; Naruse I; Nomoto T; Ishihara S; Takise A; Ezawa K; Fueki N; Hoshino H; Saito R; Mori M
    Am J Clin Oncol; 1996 Jun; 19(3):245-8. PubMed ID: 8638534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.
    Saito H; Shimokata K; Yamamoto M; Saka H; Sakai S; Saito H
    Cancer Chemother Pharmacol; 1993; 32(2):134-6. PubMed ID: 8387399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung.
    Schiller JH; Storer B; Dreicer R; Rosenquist D; Frontiera M; Carbone PP
    J Natl Cancer Inst; 1989 Nov; 81(22):1739-43. PubMed ID: 2553993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer.
    Rixe O; Coeffic D; Orcel B; Maitre B; Borel C; Benhammouda A; Petit T; Khayat D; Derenne JP
    Am J Clin Oncol; 1997 Apr; 20(2):128-31. PubMed ID: 9124184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.
    Font A; Moyano AJ; Puerto JM; Tres A; Garcia-Giron C; Barneto I; Anton A; Sanchez JJ; Salvador A; Rosell R
    Cancer; 1999 Feb; 85(4):855-63. PubMed ID: 10091762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
    Laurie SA; Pfister DG; Kris MG; Tong WP; Chronowski G; Pisters KM; Heelan RT; Sirotnak FM
    Clin Cancer Res; 2001 Mar; 7(3):501-9. PubMed ID: 11297240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
    Klastersky J; Sculier JP; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R; Dabouis G
    J Clin Oncol; 1989 Aug; 7(8):1087-92. PubMed ID: 2547028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.
    Kalemkerian GP; Jiroutek M; Ettinger DS; Dorighi JA; Johnson DH; Mabry M
    Cancer; 1998 Sep; 83(6):1102-8. PubMed ID: 9740074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
    Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
    Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.